Wolverine Trading’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Wolverine Trading’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,000	Closed	-$23K	–	6560
2018 Q2	$23K	Hold	15,000	–	–	﹤0.01%	5012
2018 Q1	$23K	Buy	+15,000	New	+$26.2K	﹤0.01%	5012
2017 Q4	–	Sell	-37,400	Closed	-$86K	–	6014
2017 Q3	$86K	Sell	37,400 -1,300	-3%	-$1.74K	﹤0.01%	4119
2017 Q2	$54K	Sell	38,700 -9,700	-20%	-$14K	﹤0.01%	4046
2017 Q1	$106K	Buy	+48,400	New	+$182K	﹤0.01%	3802
2016 Q4	–	Sell	-80,200	Closed	-$387K	–	5785
2016 Q3	$387K	Buy	80,200 +61,500	+329%	+$280K	﹤0.01%	2895
2016 Q2	$63K	Buy	+18,700	New	+$70.6K	﹤0.01%	3771

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wolverine Trading's ARLZ Position: Q3 2018 in Review

Wolverine Trading sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 11,921 shares — an estimated $18K sold.

Wolverine Trading first reported a position in ARLZ in Q2 2016 and held it in 5 quarters. The position peaked at $120K in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Wolverine Trading reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Wolverine Trading sold 11,921 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $18K.
Wolverine Trading first reported a position in Aralez Pharmaceuticals Inc. in Q2 2016 and held it in 5 quarters.
Wolverine Trading's Aralez Pharmaceuticals Inc. position peaked at $120K in Q3 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Wolverine Trading's 13F filing for Q3 2018, filed 14 Nov 2018.